MedTrace Logo

Molecular Analysis of Gastric and OEsophageal Cancers STudy

NCT06702384 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-02-06

No results posted yet for this study

Summary

A prospective translational tissue collection study to identify biomarkers predictive of treatment response/resistance and biomarkers of prognostic value from a series of patients who are investigated for and diagnosed with early or advanced gastric/junctional or oesophageal cancer (oesophagogastric cancer) at The Royal Marsden Hospital.

Conditions

  • Adenocarcinoma Esophagus
  • Adenocarcinoma of the Stomach
  • Adenocarcinoma - GEJ
  • Squamous Cell Car. - Esophagus

Interventions

DIAGNOSTIC_TEST

biopsy

Baseline biopsy and biological specimens

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dr Avani Athauda · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2027-05-31
Completion
2030-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06702384 on ClinicalTrials.gov